Evusheld Archives -

GlaxoSmithKline and Vir’s Xevudy has become the latest COVID-19 antibody therapy to have its use restricted by the

FDA restricts GSK’s Xevudy due to lower efficacy against BA.2

https://pharmaphorum.com/news/fda-restricts-gsks-xevudy-due-to-lower-efficacy-against-ba-2/

AstraZeneca confirmed today that it has discontinued clinical development of a follow-up to its COVID-19 vaccine Vaxzevria targeted

AZ halts development of Beta variant COVID-19 vaccine

https://pharmaphorum.com/news/az-halts-development-of-beta-variant-covid-19-vaccine/

AstraZeneca’s antibody cocktail for COVID-19, now called Evusheld, has become the first drug in the class to be

AZ’s antibody first to be cleared by FDA for COVID prevention

https://pharmaphorum.com/news/azs-antibody-first-to-be-cleared-by-fda-for-covid-prevention/

Evusheld